Redefining Therapeutic Paradigms for Microtubule Inhibitors

Physicians Education Resource
Archive
-
05.06.2010  Chicago
Not an official event of the ASCO Annual Meeting. Not sponsored or endorsed by ASCO or the ASCO Cancer Foundation.
 
Course Content
Satellite symposium will highlight advances in the use of novel cytotoxic agents for the treatment of metastatic breast cancer (MBC), non–small-cell lung cancer (NSCLC), pancreatic cancer, and melanoma. Recent data indicate that novel taxane formulations and other microtubule-interacting agents might improve the therapeutic index in MBC and NSCLC. In addition, these agents are demonstrating activity in melanoma and pancreatic cancer, malignancies that have been resistant to traditional...
Learning objectives, training objectives
Please see our websie for all the details www.cancerlearning.com
Target Audience
medical, surgical, and radiation oncologists interested in the treatment of patients with breast cancer, NSCLC, pancreatic cancer, and melanoma. Fellows, nurse practitioners, nurses, physician assistants, practitioners, nurses, physician assistants
Notes
http://www.cancerlearning.com/index.cfm/fuseaction/conference.showOverview/id/5/conference_id/548
 

Enquiries and Registration:

Mr. Duane Fowler
 
Categories
Oncology
Languages
English
Fees
no registration fee
Organizer contact info
3500 Maple Ave. Ste. 700
75219 Dallas
USA
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

Österreichische Gesellschaft für Public HealthFFG - 7. EU-RahmenprogrammCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioAnästhesie in Entwicklungsländern e. V.Helix - Forschung & Beratung WienEuropean Health Forum GasteinÄrzte der WeltSwiss Tropical and Public Health Institute

Facebook

Give us your professional opinion

Start survey

Start survey